Prevalence, Risk Factors, and Impact of Myopic Macular Degeneration on Visual Impairment and Functioning Among Adults in Singapore.

Published

Journal Article

Purpose: To determine the prevalence, risk factors, and impact of myopic macular degeneration (MMD) on visual impairment and functioning among adults in Singapore. Methods: A comprehensive eye examination, including subjective refraction, axial length, and visual acuity (VA) measurements, was performed in adults aged ≥40 years in the Singapore Epidemiology of Eye Diseases (SEED) study. From fundus photographs, MMD was graded using the International META-PM classification. Vision-specific functioning (VSF) was assessed with a validated visual-functioning questionnaire (VF-11) using Rasch analysis. Results: A total of 8716 phakic subjects were included in this analysis. The mean age (± SD) was 57.2 ± 9.5 years (33.5% Malays, 33.2% Indians, and 33.3% Chinese). The prevalence of myopia (spherical equivalent [SE] ≤ -0.5 diopters [D]) and high myopia (SE ≤ -5.0 D) was 35.7% and 6.0%, respectively. The age-standardized prevalence of MMD was 3.8% (95% confidence interval [CI], 3.4-4.3%). The prevalence of MMD was 7.7% among low to moderate myopes, and 28.7% among high myopes. The prevalence of MMD increased nonlinearly with SE and age. MMD was associated with older age, more myopic SE, and lower education. Subjects with Meta-PM categories 3 or 4 in the better-seeing eye had worse best-corrected VA (β, 0.19; 95%CI, 0.16-0.23) and poorer VSF (β, -9.7; 95%CI, -17.6 to -1.8) than those without MMD after multivariate adjustments. Conclusions: Approximately 1 in 26 phakic adults in Singapore has MMD. Older age and myopic SE are major risk factors of MMD. Severe MMD has a substantial impact on visual impairment and functioning.

Full Text

Duke Authors

Cited Authors

  • Wong, Y-L; Sabanayagam, C; Ding, Y; Wong, C-W; Yeo, AC-H; Cheung, Y-B; Cheung, G; Chia, A; Ohno-Matsui, K; Wong, T-Y; Wang, JJ; Cheng, C-Y; Hoang, QV; Lamoureux, E; Saw, S-M

Published Date

  • September 4, 2018

Published In

Volume / Issue

  • 59 / 11

Start / End Page

  • 4603 - 4613

PubMed ID

  • 30242361

Pubmed Central ID

  • 30242361

Electronic International Standard Serial Number (EISSN)

  • 1552-5783

Digital Object Identifier (DOI)

  • 10.1167/iovs.18-24032

Language

  • eng

Conference Location

  • United States